🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the effect of erdafitinib alone to using the c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-12
Trial ID
NCT05564416
This phase Ib/II trial studies the side effects, best dose, and effectivene...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2025-03-31
Trial ID
NCT06470282
This phase II trial studies the benefit of adding an immunotherapy drug cal...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-03-17
Trial ID
NCT04216290
This phase II/III trial examines whether patients who have undergone surgic...
Status
Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2024-02-02
Trial ID
NCT05987241
This phase III trial studies how well chemotherapy and radiation therapy wo...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2019-06-03
Trial ID
NCT03775265
The aim of this randomised parallel trial is to compare the efficacy of Gly...
Status
Withdrawn
Location
Hampshire Hospitals NHS Foundation Trust
Start Date
2019-04-30
Trial ID
NCT03861260
This phase III trial studies how well pembrolizumab works in treating patie...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-03
Trial ID
NCT03244384
This phase II trial tests the effect of giving pembrolizumab in combination...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-11-25
Trial ID
NCT07061964
This pilot feasibility clinical trial is evaluating a novel treatment strat...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-08-20
Trial ID
NCT07579195
Treatments Being Tested
This phase II trial studies the effect of adding pembrolizumab to gemcitabi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-03-18
Trial ID
NCT04164082